17-47941687-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_018129.4(PNPO):c.12G>T(p.Trp4Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000227 in 1,539,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018129.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPO | NM_018129.4 | c.12G>T | p.Trp4Cys | missense_variant | 1/7 | ENST00000642017.2 | NP_060599.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPO | ENST00000642017.2 | c.12G>T | p.Trp4Cys | missense_variant | 1/7 | NM_018129.4 | ENSP00000493302 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000144 AC: 22AN: 152254Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000667 AC: 1AN: 149974Hom.: 0 AF XY: 0.0000125 AC XY: 1AN XY: 79722
GnomAD4 exome AF: 0.00000937 AC: 13AN: 1387088Hom.: 0 Cov.: 31 AF XY: 0.00000732 AC XY: 5AN XY: 682684
GnomAD4 genome AF: 0.000144 AC: 22AN: 152254Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74386
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 20, 2019 | In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Pyridoxal phosphate-responsive seizures Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 24, 2022 | This sequence change replaces tryptophan, which is neutral and slightly polar, with cysteine, which is neutral and slightly polar, at codon 4 of the PNPO protein (p.Trp4Cys). This variant is present in population databases (rs773614378, gnomAD 0.06%). This variant has not been reported in the literature in individuals affected with PNPO-related conditions. ClinVar contains an entry for this variant (Variation ID: 206439). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at